N@N

Law Office of Brodsky & Smith, LLC Announces Investigation of Acxiom Corporation

_{//science-technology.news-articles.net/content/2 .. nounces-investigation-of-acxiom-corporation.html}
^{Published in Science and Technology on Wednesday, May 11th 2011 at 9:35 GMT by Market Wire}  

BALA CYNWYD, Pa.--([ BUSINESS WIRE ])--Law office of Brodsky & Smith, LLC announces that it is investigating Acxiom Corporation (aAcxioma or the aCompanya) (Nasdaq: ACXM) investment of Plan participants and beneficiaries assets in company stock. The investigation concerns whether administrators breached their fiduciary duties and violated the Employee Retirement Income Security Act of 1974 (aERISAa) by investing and/or continuing to invest assets in company stock when it was not a prudent investment for participantsa™ retirement savings.

The investigation concerns improper behavior that harmed current and former employees that invested in the 401(k) plan. Specifically, administrators failed to disclose the decline in its international operations; that the Company failed to properly and timely account for impaired assets related to its international operations; and that, as a result, defendantsa™ statements regarding Acxioma™s financial performance and expected earnings were misleading. The company announced on March 30, 2011 that its CEO and President had resigned and shares of the Company fell over 22% to approximately $13.50 a share.

If you held Acxiom stock in an individual account under any of the Companya™s 401(k) plans and wish to discuss the legal ramifications of the administratora™s investment in Company stock, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ], visiting [ http://brodsky-smith.com/288-acxm-acxiom-corporation.html ], or by calling toll free 877-LEGAL-90.